Parkman Healthcare Partners’s Mettler-Toledo International MTD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,988
Closed -$15.3M 104
2025
Q4
$15.3M Buy
+10,988
New +$15.3M 1.46% 22
2024
Q1
Sell
-7,500
Closed -$9.1M 111
2023
Q4
$9.1M Buy
+7,500
New +$8.11M 1.28% 27

Other funds holding MTD

Parkman Healthcare Partners's MTD Position: Q1 2026 in Review

Parkman Healthcare Partners sold out of Mettler-Toledo International (MTD) in Q1 2026, closing a stake of 10,988 shares — an estimated $15.3M sold.

Parkman Healthcare Partners first reported a position in MTD in Q4 2023 and held it in 2 quarters. The position peaked at $15.3M in Q4 2025. 821 funds tracked by Wall St. Rank hold MTD as of Q1 2026.

  • Parkman Healthcare Partners reported no remaining Mettler-Toledo International position as of Q1 2026 after selling out during the quarter.
  • Parkman Healthcare Partners sold 10,988 Mettler-Toledo International shares in Q1 2026, an estimated $15.3M.
  • Parkman Healthcare Partners first reported a position in Mettler-Toledo International in Q4 2023 and held it in 2 quarters.
  • Parkman Healthcare Partners's Mettler-Toledo International position peaked at $15.3M in Q4 2025.
  • 821 funds tracked by Wall St. Rank held Mettler-Toledo International as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.